BioSpace News Archive

Cytocom, Inc., a leading biopharmaceutical company in the area of immune-modulation, today announced that its Chief Executive Officer, Michael K. Handley, has issued a Letter to the stockholders of Cytocom and Cleveland BioLabs, Inc. (NASDAQ: CBLI) regarding the recently announced merger between the companies.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Evrysdi™ (risdiplam) was approved in Brazil by the National Health Surveillance Agency (ANVISA) for the treatment of spinal muscular atrophy (SMA).

Registration is now open for the World Cord Blood Day 2020 virtual conference (register free on Eventbrite) featuring world renown cord blood transplant doctors and cellular therapy researchers.

Increased Agility from Incentive Compensation Teams Needed to Meet the Rapidly Changing Environment Amid COVID-19, According to the New TGaS Report from Trinity Life Sciences

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based therapeutic formulations and medicines, announced today that it has signed an agreement with a leading clinical quality and validation processes consultancy to oversee the preparation and submissi

Represents largest dd-cfDNA retransplant study to date and demonstrates clinical value of proprietary background cfDNA technology

HCA Healthcare , one of the nation’s leading healthcare providers, today announced its second annual national “Crush the Crisis” event to raise awareness about the dangers of opioid misuse and proper disposal of medications. On Saturday, October 24, in alignment with the Drug Enforcement Administration’s (DEA) National Prescription Drug Take Back Day, approximately 95 HCA Healthcare facilities across 16 states will par

ABEC , a leading global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced it is delivering process systems to Ology Bioservices Inc. (Ology Bio) to support their production of critical vaccines and therapeutics for COVID-19. ABEC is providing these systems to Ology Bios

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless cervical cancer detection test based on its patented biophotonic technology, announced today the successful outcome of its October 14, 2020 meeting with FDA. The purpose of the meeting was to finalize the protocol (procedure) for its n

Verista, an industry-leading solutions provider to some of the world’s most recognizable brands, officially unveiled its new name , the result of unifying Clarke Solutions, Covex LLC and Acquire Automation.